X-CUTAG is a China-rooted, globally engaged biotech start-up driving therapeutic innovation through systematic technology iteration. By forging strategic alliances with top-tier academic institutions, CRO partners, and multinational pharma leaders, we accelerate the commercialization of clinically meaningful drug candidates, translating scientific breakthroughs into accessible therapies for global patient populations.
Our proprietary AcuMed InnovationsTM platform, engineered through the synthesis of vast drug development datasets and frontline clinical insights, empowers end-to-end R&D transformation. From target deconvolution to trial-ready molecule optimization, this AI-orchestrated system redefines how medicines are born, validated, and delivered to those who need them most.
